Expert review

Safety and efficacy of biodegradable vs. durable polymer drug-eluting stents: evidence from a meta-analysis of randomised trials

EuroIntervention 2011;7:985-994 publish online ahead of print November 2011. DOI: 10.4244/EIJV7I8A155

Eliano Pio Navarese
Eliano Pio Navarese1*, MD, FEAPCI; Jacek Kubica1, MD, PhD; Fausto Castriota2, MD, FESC; C. Michael Gibson3, MS, MD, FACC; Giuseppe De Luca4, MD, PhD; Antonino Buffon5, MD; Leonardo Bolognese6, MD; Massimo Margheri7, MD; Felicita Andreotti5, MD, PhD, FESC; Carlo Di Mario8, MD, FESC; Stefano De Servi9, MD, FESC
1. Department of Cardiology and Internal Medicine, Ludwik Rydygier Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland; 2. GVM Care and Research, Interventional Cardio-Angiology Unit, Cotignola, Italy; 3. Cardiovascular

Aims: Drug-eluting stents (DES) are a major advance in interventional cardiology; however concerns have been raised regarding their long-term sa

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

biodegradable stentclinical researchrandomised controlled trialslate thrombosismeta-analysis
Read next article
How should I treat a patient with left main disease and a totally occluded left anterior descending artery with a diseased saphenous venous graft?

Latest news